Bangying Su

Corporate Officer/Principal bei Washington University in St. Louis

Consumer Services

Health Technology

Aktive Positionen von Bangying Su

Unternehmen	Position	Beginn	Ende
Washington University in St. Louis	Corporate Officer/Principal	25.01.2010	-
The University of Alabama	Corporate Officer/Principal	25.01.2010	-

Unternehmen	Position	Beginn	Ende
Dynamis Therapeutics, Inc. Dynamis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Therapeutics, Inc. operates as a holding company with interests in developing pharmaceuticals and diagnostics. It operates through its subsidiaries Dynamis Pharmaceuticals, Inc. and Dynamis Skin Science. The firm's product DYN 15, a drug candidate that prevents the formation of 3DG, a reactive sugar, as well as decreases the levels of key cytokines that are stimulated in chronic inflammations. The company was founded by Annette M. Tobia on May 21, 1997 and is headquartered in Jenkintown, PA.	Corporate Officer/Principal	25.01.2010	-

Peking University

Undergraduate Degree

International

Vereinigte Staaten	4
China	2

Operativ

Corporate Officer/Principal	3
Undergraduate Degree	1

Sektoral

Consumer Services	4
Health Technology	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	1
Dynamis Therapeutics, Inc. Dynamis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Therapeutics, Inc. operates as a holding company with interests in developing pharmaceuticals and diagnostics. It operates through its subsidiaries Dynamis Pharmaceuticals, Inc. and Dynamis Skin Science. The firm's product DYN 15, a drug candidate that prevents the formation of 3DG, a reactive sugar, as well as decreases the levels of key cytokines that are stimulated in chronic inflammations. The company was founded by Annette M. Tobia on May 21, 1997 and is headquartered in Jenkintown, PA.	Health Technology

Private Unternehmen

Health Technology